United Kingdom of Great Britain and Northern Ireland vs World: Access to anti-retroviral drugs, female

United Kingdom of Great Britain and Northern Ireland
96.0%
in 2023
World
83.0%
in 2024
United Kingdom of Great Britain and Northern Ireland rank
14th
World rank
15th

Access to anti-retroviral drugs, female over time

  • United Kingdom of Great Britain and Northern Ireland
  • World
020406080100200020122024

How they compare

United Kingdom of Great Britain and Northern Ireland currently reports 96.0% against 83.0% in World, a difference of 13.0%.

That makes United Kingdom of Great Britain and Northern Ireland's figure about 1.2 times World's.

Across all 8 years both countries report, United Kingdom of Great Britain and Northern Ireland has been ahead every year.

United Kingdom of Great Britain and Northern Ireland ranks 14th and World ranks 15th of 141 countries.

United Kingdom of Great Britain and Northern Ireland has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade United Kingdom of Great Britain and Northern Ireland World Difference Ahead
2010s 88.0% 64.8% 23.2% United Kingdom of Great Britain and Northern Ireland
2020s 90.8% 77.0% 13.8% United Kingdom of Great Britain and Northern Ireland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, female, United Kingdom of Great Britain and Northern Ireland or World?
United Kingdom of Great Britain and Northern Ireland, at 96.0% against 83.0% in World as of 2023.
What is the difference in access to anti-retroviral drugs, female between United Kingdom of Great Britain and Northern Ireland and World?
13.0%, with United Kingdom of Great Britain and Northern Ireland ahead.
How many years of comparable data are there for United Kingdom of Great Britain and Northern Ireland and World?
8 years are reported by both, from 2016 to 2023.
How do United Kingdom of Great Britain and Northern Ireland and World rank globally for access to anti-retroviral drugs, female?
United Kingdom of Great Britain and Northern Ireland ranks 14th and World ranks 15th of 141 countries.
Where does this data come from?
UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

United Kingdom of Great Britain and Northern Ireland vs World: Access to anti-retroviral drugs, female. Statizoid, drawing on UNAIDS estimates. Retrieved 16 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/united-kingdom/world/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/united-kingdom/world/">United Kingdom of Great Britain and Northern Ireland vs World: Access to anti-retroviral drugs, female</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.